Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare
“Protein pharmaceuticals represent a multibillion-dollar market, but deciphering the most suitable biotherapeutic-producing cell lines is a substantial manufacturing bottleneck”, writes Lauren Tanabe for a recent article published by BioCompare. CHO cells have been the expression system of choice for producing biological therapies for several decades; they are accepted by the FDA, easy to work with, …
Read more Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare